Historical Information on Erythropoiesis Stimulating Agents (ESA)
(marketed as Procrit, Epogen, and Aranesp)

June 26, 2007

• Statement of John K. Jenkins, M.D., regarding erythropoiesis-stimulating agents (ESA) before the Committee on Ways and Means Subcommittee on Health, U.S. House of Representatives

March 9, 2007

• FDA News: FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)
• Questions and Answers
• Information for Healthcare Professionals
• Public Health Advisory

November 16, 2006

• Information for Healthcare Professionals
• Public Health Advisory
  

Back to Top     Back to ESAs

PDF requires the free Adobe Acrobat Reader

Date created: January 3, 2008

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research